77 related articles for article (PubMed ID: 3912040)
1. Comparison of the antiemetic efficacy of two high-dose benzamides, metoclopramide and alizapride, against cisplatin-induced emesis.
Saller R; Hellenbrecht D
Cancer Treat Rep; 1985 Nov; 69(11):1301-3. PubMed ID: 3912040
[TBL] [Abstract][Full Text] [Related]
2. [Control of the emesis induced by cisplatin in patients with head and neck neoplasms. Randomized study of metoclopramide alizapride and placebo].
Denaro A; Rossi M; Garozzo A; Matera M; Neri V
G Ital Oncol; 1990; 10(1-2):29-34. PubMed ID: 2192985
[TBL] [Abstract][Full Text] [Related]
3. Dose-response relationships of the objective and subjective antiemetic effects and of different side effects of metoclopramide against cisplatin induced emesis.
Hellenbrecht D; Saller R
Arzneimittelforschung; 1986 Dec; 36(12):1845-9. PubMed ID: 3566848
[TBL] [Abstract][Full Text] [Related]
4. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
[TBL] [Abstract][Full Text] [Related]
5. [Phase I study of alizapride in cancer patients treated with cisplatin].
Nicaise C; Rozencweig M; Ortmans M; Frisque C; Bleiberg H
Sem Hop; 1983 Sep; 59(31):2161-5. PubMed ID: 6312589
[TBL] [Abstract][Full Text] [Related]
6. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
[TBL] [Abstract][Full Text] [Related]
7. High doses of metoclopramide or droperidol in the prevention of cisplatin-induced emesis.
Saller R; Hellenbrecht D
Eur J Cancer Clin Oncol; 1986 Oct; 22(10):1199-203. PubMed ID: 3545851
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study on the tolerance and efficacy of high doses of metoclopramide and clebopride in vomiting induced by cisplatin].
Martín M; Díaz-Rubio E
Med Clin (Barc); 1989 Jun; 93(2):50-3. PubMed ID: 2755259
[TBL] [Abstract][Full Text] [Related]
9. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
10. [Alizapride in upper digestive endoscopy. A double-blind study vs metoclopramide and placebo].
Bongiorno A; Cataldo MG; Salvia A; D'Aiuto A; Ciranni C
Minerva Dietol Gastroenterol; 1989; 35(4):265-8. PubMed ID: 2695861
[TBL] [Abstract][Full Text] [Related]
11. [Alizapride in a double-blind trial with metoclopramide in nausea and vomiting caused by radiotherapy].
Budach V; Krüger K
Fortschr Med; 1983 Oct; 101(39):1792-4. PubMed ID: 6642386
[TBL] [Abstract][Full Text] [Related]
12. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
13. A prospective randomized double-blind crossover study comparing the antiemetic activity of alizapride and metoclopramide in patients receiving cisplatin chemotherapy.
Basurto C; Roila F; Del Favero A; Ballatori E; Minotti V; Tonato M
Cancer Invest; 1988; 6(5):475-9. PubMed ID: 3063335
[TBL] [Abstract][Full Text] [Related]
14. [Antiemetic combination of metoclopramide and methylprednisolone for cisplatin-induced vomiting].
Saito H; Amano H; Yasuda Y; Tsunekawa H; Fujimoto K; Yoshii S; Shimokata K
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1980-2. PubMed ID: 4051514
[TBL] [Abstract][Full Text] [Related]
15. Comparison of ondansetron-dexamethasone-lorazepam versus metoclopramide-dexamethasone-lorazepam in the control of cisplatin induced emesis.
Manusirivithaya S; Chareoniam V; Isariyodom P; Sungsab D
J Med Assoc Thai; 2001 Jul; 84(7):966-72. PubMed ID: 11759977
[TBL] [Abstract][Full Text] [Related]
16. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
17. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
18. [Comparative double-blind study: alizapride-metoclopramide].
Oberling F
Ann Gastroenterol Hepatol (Paris); 1984; 20(1):59-61. PubMed ID: 6529162
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing alizapride alone or with dexamethasone vs a metoclopramide-dexamethasone combination for emesis induced by moderate-dose cisplatin.
Pollera CF; Nardi M; Marolla P; Carlini P
Cancer Chemother Pharmacol; 1987; 19(4):335-8. PubMed ID: 3297376
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic activity of two different high doses of metoclopramide in cisplatin-treated cancer patients: a randomized double-blind trial of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Canaletti R; Morsia D; Passalacqua R; DiCostanzo F; Donati D; Colombo N; Ballatori E
Cancer Treat Rep; 1985 Dec; 69(12):1353-7. PubMed ID: 3907824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
